EUVIMEDEUVIMED entdecken
Crossref

Urolithin A ameliorates schizophrenia-like behaviors and cognitive impairments in female rats by modulating NLRP3 signaling

Zhengyuan Huang, Guanghui Chen, Zhongyu Ren, Ling Xiao, Ziyue Chen, Yinping Xie, Gaohua Wang, Benhong Zhou

International Immunopharmacology · 2025-04 · 151 · 114336

DOI: 10.1016/j.intimp.2025.114336 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025-04. Verfasst von Zhengyuan Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan 430060, China; Department of Pharmacy, Renmin Hospital of Wuhan University, Wuha…. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Schizophrenia, Cognitive Dysfunction, Coumarins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The management of cognitive impairments in schizophrenia presents a considerable challenge, with a strong association between neuroinflammation and its progression. Urolithin A (UA) demonstrates important anti-inflammatory properties in multiple neurological disease models, contributing to the enhancement of cognitive deficits. However, it remains uncertain if UA can produce comparable neuroregulatory effects in female rat models of schizophrenia. Eight-week-old female Sprague Dawley rats received either 0.1 mg/kg of MK801 or volume-matched saline via intraperitoneal injection for 5 consecutive days. Furthermore, they were administered 150 mg/kg of UA through oral gavage for 4 weeks. Behavioral assessments were performed to evaluate cognitive function and behavior after UA treatment. Immunofluorescence staining was employed to assess microglial activity in the hippocampus, while Western blot analysis was conducted to investigate the expression of neuroinflammation-associated proteins. Prolonged exposure to MK801 induces schizophrenia-like behaviors and cognitive deficits in female rats. It also elevates the expression of NLRP3, Caspase-1, IL-1β, and IL-18 proteins in the hippocampus, accompanied by the activation of microglial cells. However, UA treatment can reverse the expression of these inflammatory proteins and the activation of microglial cells induced by MK801. This is the first study to evaluate the effects of UA on behavior and cognition in a female rat model of schizophrenia. The findings indicate that UA mitigates MK-801-induced cognitive deficits in female rats by inhibiting neuroinflammation and microglial activation via modulation of the NLRP3 signaling pathway. These findings offer preclinical data endorsing the possible application of UA as a dietary supplement to prevent cognitive deficits in schizophrenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinSchizophreniaCognitive DysfunctionCoumarinsAnti-Inflammatory AgentsAnimalsFemaleRats, Sprague-DawleyRatsSignal TransductionDisease Models, AnimalMicrogliaHippocampusDizocilpine MaleateBehavior, AnimalInflammasomes

Stichwörter der Autor:innen

Cognitive functionNLRP3NeuroinflammationSchizophreniaUrolithin A

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinCoumarinsNlrp3 protein, rat3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneDizocilpine MaleateAnti-Inflammatory AgentsInflammasomes

Autor:innen und Institutionen

  • Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan 430060, China; Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan 430060, China.
  • Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan 430060, China.
  • Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan 430060, China.
  • Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan 430060, China; Institute of Neuropsychiatry, Renmin Hospital of Wuhan University, Wuhan 430060, China.
  • Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan 430060, China; Institute of Neuropsychiatry, Renmin Hospital of Wuhan University, Wuhan 430060, China; Taikang center for life and medical sciences, W…
  • Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan 430060, China; Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan 430060, China. Electronic address: benhongzh@whu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Huang, Z., Chen, G., Ren, Z., Xiao, L., Chen, Z., Xie, Y., Wang, G., & Zhou, B. (2025). Urolithin A ameliorates schizophrenia-like behaviors and cognitive impairments in female rats by modulating NLRP3 signaling. International Immunopharmacology, 151, 114336. https://doi.org/10.1016/j.intimp.2025.114336

Vancouver

Huang Z, Chen G, Ren Z, Xiao L, Chen Z, Xie Y, et al. Urolithin A ameliorates schizophrenia-like behaviors and cognitive impairments in female rats by modulating NLRP3 signaling. International Immunopharmacology. 2025;151:114336. doi:10.1016/j.intimp.2025.114336

BibTeX
@article{Huang2025,
  author = {Huang, Zhengyuan and Chen, Guanghui and Ren, Zhongyu and Xiao, Ling and Chen, Ziyue and Xie, Yinping and Wang, Gaohua and Zhou, Benhong},
  title = {Urolithin A ameliorates schizophrenia-like behaviors and cognitive impairments in female rats by modulating NLRP3 signaling},
  journal = {International Immunopharmacology},
  year = {2025},
  volume = {151},
  pages = {114336},
  doi = {10.1016/j.intimp.2025.114336}
}
Kostenlos starten →